戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ein, lactate dehydrogenase, electrolytes, or urine albumin.
2 tive sample of subjects, the distribution of urine albumin and creatinine concentrations was examined
3 assessment of albuminuria includes measuring urine albumin and creatinine in an untimed spot urine co
4                               HGF attenuated urine albumin and total protein excretion in diabetic mi
5                                              Urine albumin changes rapidly within the first 6 hrs fol
6                                              Urine albumin concentrations increased in all salsalate
7                                         Mean urine albumin concentrations were not significantly diff
8  blacks (NHB) and Mexican Americans, whereas urine albumin concentrations were significantly higher i
9 ants and baseline information about eGFR and urine albumin concentrations.
10 ed hypertension (P < 0.001), the increase of urine albumin creatinine ratio (P < 0.01), the fall in g
11 re considered to have an abnormally elevated urine albumin creatinine ratio if the value was >/=17 mg
12 ell as the threshold reference value for the urine albumin creatinine ratio in the adult intensive ca
13 ned as eGFR <60 mL.min(-1).1.73 m(-2) and/or urine albumin-creatinine ratio >300 mg/g) at baseline.
14 0, >/=90 mL.min(-1).1.73 m(-2)) and baseline urine albumin-creatinine ratio (>300, 30-</=300, <30 mg/
15                                              Urine albumin-creatinine ratio (ACR) was measured on ICU
16  serum creatinine, estimated GFR (eGFR), and urine albumin-creatinine ratio (UACR) in search of genet
17 identified 5,968 with available preoperative urine albumin-creatinine ratio (UACR) measurements.
18 ns that adjusted for known risk factors, the urine albumin-creatinine ratio (UACR) was a significant
19 ere consistent across categories of eGFR and urine albumin-creatinine ratio at baseline and across th
20 R of at least 60 mL/min/1.73 m2 and a 1-time urine albumin-creatinine ratio of at least 30 mg/g.
21 in the simvastatin-treated group, as was the urine albumin-creatinine ratio on day 7 postsurgery.
22 seline brachial artery diameter (PAI-1, CRP, urine albumin-creatinine ratio), baseline mean flow (N-A
23 ive protein [CRP]), and target organ damage (urine albumin-creatinine ratio).
24  reactive hyperemia (BNP, PAI-1, CRP, renin, urine albumin-creatinine ratio).
25 ducts and systemic endothelial injury by the urine albumin-creatinine ratio.
26                      We measured serial spot urine albumin-creatinine ratios in 104 critically ill pa
27 L/min/1.73 m, P=0.21) and albumin excretion (urine albumin/ creatinine 9.76+/-23.6 mg/g vs. 5.91+/-11
28  filtration rate <60 mL/min per 1.73 m(2) or urine albumin/creatinine >30 mg/g) and available echocar
29 s (p = 0.002), MS (p = 0.003) and higher log urine albumin/creatinine (p = 0.005).
30 1.3 vs. 1.0+/-1.0 mg/dl, p<0.001) and higher urine albumin/creatinine levels (3.6+/-2.3 vs. 3.3+/-2.0
31 ) at a 1992-1996 research clinic visit, when urine albumin/creatinine ratio (ACR) was measured in spo
32 dex (BMI), glomerular filtration rate (GFR), urine albumin/creatinine ratio (ACR), hypertension, majo
33 raacetic acid clearance) was associated with urine albumin/creatinine ratio (UACR) post-HTx in a subg
34 rotein cholesterol, creatinine, glucose, and urine albumin/creatinine ratio as standard risk factors,
35 mplete blood count, serum creatinine level), urine albumin/creatinine ratio measure, and a measure of
36 sterol, smoking, and medications that affect urine albumin:creatinine ratio (ACR).
37 incident CKD, albuminuria (defined as a spot urine albumin:creatinine ratio of >30 mg/g or albumin ex
38 C concentrations, and microalbuminuria using urine albumin:creatinine ratios.
39 eduction with once-daily diltiazem decreased urine albumin excretion (2967 +/- 784 mg/d at baseline c
40 =192) and albumin-creatinine ratio and 24-hr urine albumin excretion (n=189) in stable renal transpla
41 tion, specifically serum uric acid (SUA) and urine albumin excretion (UAE), and that high sodium inta
42                                     Elevated urine albumin excretion (UAER) is a modifiable risk fact
43 s admixture to identify associations between urine albumin excretion (urine albumin-to-creatinine rat
44 us studies have found an association between urine albumin excretion and Amerindian ancestry in Hispa
45  assessment of GFR in addition to monitoring urine albumin excretion and funduscopic changes to ensur
46 eated diabetic mice (P < 0.04) and had lower urine albumin excretion at 10 weeks than VEH-treated dia
47 ecific variants influencing the variation of urine albumin excretion in Hispanics/Latinos.
48                                    Increased urine albumin excretion is highly prevalent in Hispanics
49      There was no detectable increase in the urine albumin excretion of Ptpro(-/-) mice.
50                 Macroalbuminuria, defined as urine albumin excretion rate (AER)>/=300 mg/d, has long
51 ted from podocytes exhibited an elevation in urine albumin excretion that was accompanied by increase
52                                              Urine albumin excretion was significantly increased in 3
53 wever, the independent graded association of urine albumin excretion with AKI is unknown.
54 nth-old mice revealed a 1.7-fold increase in urine albumin excretion, accelerated glomerulosclerosis,
55 t of diabetic nephropathy with elevations in urine albumin excretion, glomerular and renal hypertroph
56 sociation of urinary albumin excretion (spot urine albumin indexed to creatinine [UACR]) and the inci
57 ld G6PD-deficient mice (17-20 mo) had higher urine albumin levels and also had evidence for increased
58                                       Serial urine albumin measurement may provide a means of monitor
59  greater albuminuria (422 versus 158 micro g urine albumin/mg urine creatinine; P = 0.01).
60 -2.28+/-0.85 ml/min per SD, P=0.008) but not urine albumin (P=0.09).
61 fined as diabetes with albuminuria (ratio of urine albumin to creatinine >/=30 mg/g), impaired glomer
62 cts underwent uric acid, iothalamte GFR, and urine albumin to creatinine (ACR) measurements annually
63 lf-reported hypertension), microalbuminuria (urine albumin to creatinine ratio >30 mg/g), and chronic
64 mated from calibrated serum creatinine, spot urine albumin to creatinine ratio (ACR), age, gender, an
65 c for ESRD but is poorly captured by eGFR or urine albumin to creatinine ratio (ACR).
66 Spot urine protein to creatinine ratio, spot urine albumin to creatinine ratio, creatinine clearance,
67 imated glomerular filtration rate and higher urine albumin to creatinine ratios were associated with
68 ith diabetes, hypertension, and albuminuria (urine albumin-to-creatinine ratio > or =300 mg/g) who al
69 ) <60 ml/min per 1.73 m(2); we defined MA as urine albumin-to-creatinine ratio >/=25 (women) or 17 (m
70                                 Albuminuria (urine albumin-to-creatinine ratio >/=30 mg/g), macroalbu
71 atinine ratio >/=30 mg/g), macroalbuminuria (urine albumin-to-creatinine ratio >/=300 mg/g), reduced
72 CKD (eGFR<60 ml/min per 1.73 m(2) [n=832] or urine albumin-to-creatinine ratio >30 mg/g [n=577]).
73            The effect of hydroxyurea (HU) on urine albumin-to-creatinine ratio (ACR) is unclear and s
74  (730,577 person-years) from 14 studies with urine albumin-to-creatinine ratio (ACR) measurements and
75 ntify associations of creatinine-based eGFR, urine albumin-to-creatinine ratio (ACR), and dipstick pr
76            Diabetes increased blood glucose, urine albumin-to-creatinine ratio (ACR), kidney patholog
77  15 to <30, or <15 ml/min per 1.73 m(2)) and urine albumin-to-creatinine ratio (ACR; >300, 30-300, or
78 d GFR (eGFR) <60 ml/min per 1.73 m(2) and/or urine albumin-to-creatinine ratio (UACR) >/= 3.5 mg/mmol
79 ension, we examined the relationship between urine albumin-to-creatinine ratio (UACR) and cardiac mec
80 iltration rate [eGFR] >60 ml/min/1.73 m2 and urine albumin-to-creatinine ratio [uACR] <3 mg/mmol) at
81 ssociations between urine albumin excretion (urine albumin-to-creatinine ratio [UACR]) and genomic re
82 ) study for the association between baseline urine albumin-to-creatinine ratio and estimated GFR (eGF
83 used parameters (glomerular filtration rate, urine albumin-to-creatinine ratio and urine protein-to-c
84                   Compared with placebo, the urine albumin-to-creatinine ratio decreased by 34.0% (95
85                                          The urine albumin-to-creatinine ratio genome-wide associatio
86 .6 to 3.0), and 4.8 (95% CI, 3.2 to 7.2) for urine albumin-to-creatinine ratio groups of 11 to 29 mg/
87 ml/min per 100 g body wt, P = 0.02), and the urine albumin-to-creatinine ratio increased markedly (co
88 sted models for demographics, baseline eGFR, urine albumin-to-creatinine ratio, comorbidity, and meas
89 , human immunodeficiency virus (HIV) status, urine albumin-to-creatinine ratio, hemoglobin, and lipid
90 ant changes in VO2 peak, kidney function, or urine albumin-to-creatinine ratio.
91 not differ between groups when stratified by urine albumin-to-creatinine ratio.
92 hics, cardiovascular risk factors, eGFR, and urine albumin-to-creatinine ratio.
93 megalin, which inversely correlated with the urine albumin-to-creatinine ratio.
94                      Using participants with urine albumin-to-creatinine ratios <10 mg/g as a referen
95  an unbiased genome-wide association scan of urine albumin-to-creatinine ratios.
96                        We obtained blood and urine albumin, urea, creatinine, electrolytes, A1c, and
97                                Comparison of urine albumin within 6 hrs of intensive care unit (ICU)

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。